Home Archive
Archive
2022 Volume 53 Issue 5  Published: 2022-05-10
  • Huiyong ZHU , Yubo WU , Wangding LU , Xiaoyu YANG , Yangyang HU , Huafei LUO
    doi: 10.16522/j.cnki.cjph.2022.05.001

    Animal skins, one kind of necessary study materials, play an important role in the development of transdermal products. The barrier characteristics of skins should be considered. The 3H2O in vitro transdermal permeability and transepidermal water loss(TEWL) are effective methods and important indicators for evaluating the barrier function of skins. The results showed that the freshness, thickness, mass and steady-state TEWL were the critical quality control points of the skin model, which could further improve the reliability and accuracy of the research results. In addition, the in vitro transdermal permeability tests of total eight model drugs from seven brand-name drugs were carried out to evaluate the correlation of the permeability rate in common animal skin models(nude mouse and mini pig skins) and the drug release rate in clinical practice. This study provided a scientific basis in selecting skin model and its results indicated that pig skin, under strict quality control, was preferred to be used in predicting the pharmacokinetics profiles of transdermal products.

  • Yubo WU , Lele HUANG , Wangding LU , Huiyong ZHU , Jinlong MA , Huafei LUO , Rui NI
    doi: 10.16522/j.cnki.cjph.2022.05.002

    Compared with oral and injectable formulations, it is much more complicated in semisolid and suspension formulations for topical usage from the technical points of view. Due to the characteristics of multiple phases, irregular drug release kinetics and degradation thermodynamics, and generally without systemic absorption, the formulation development and characterization of topical semisolid drug products are facing challenges. Referring to the relevant technical guidelines issued by FDA, EMA and Center for Drug Evaluation of China as well as literature, this paper analyzes the key technical points on topical dermatologic drugs for Q3 equivalence study, including the critical quality attributes, in vitro release test(IVRT) and in vitro permeation test(IVPT), hoping to provide some references for in vitro consistency of generic drugs.

  • Lele HUANG , Jinlong MA , Jiaming WANG , Yi XU , Shengchao XU , Huiyong ZHU , Jiajun SHI , Rui NI , Huafei LUO
    doi: 10.16522/j.cnki.cjph.2022.05.003

    Rheological properties of semisolid preparations for topical skin use depend on the microstructures. Rheological behaviors may affect the manufacturing, appearance, stability, skin sensory properties, and in vivo performance of the semisolid preparations. The microstructure features of topical semisolid preparations can be characterized by rheological evaluation, which has a high application value in formulation development. The rheological parameters can serve as critical quality attributes of semisolid preparations for topical skin use, and can be used to predict storage stability and patient compliance. The general methods used for rheological evaluation are introduced and their applications in terms of formulation development, improvement in stability and patient compliance are reviewed in this paper.

  • Wangding LU , Huiyong ZHU , Ying HUANG , Xiaoyu YANG , Yangyang HU , Huafei LUO
    doi: 10.16522/j.cnki.cjph.2022.05.004

    Transdermal drug delivery system shows unique clinical advantages as well as commercial value in the development of improved new drugs. This review analyzes the characteristics of transdermal patches approved by FDA in recent years from the perspectives of improving patient compliance and drug safety, and introduces the non-clinical and clinical assessment requirements of improved transdermal patches. It is expected to provide some references for the development of improved transdermal products. Meanwhile, the critical aspects in the development process of transdermal patches are also introduced.

  • Caixia YU , Lina YANG , Jianhao TENG , Huafei LUO , Fuli ZHANG , Liya LIN
    doi: 10.16522/j.cnki.cjph.2022.05.005

    Transdermal tulobuterol patch, which contains a β2-adrenergic receptor-specific agonist, is the first long-acting bronchodilator that can be used as a transdermal patch. This paper traces the prescription and technology of the original patches and combs the research progress at home and abroad to provide ideas for the development of domestic generic tulobuterol patches.

  • Xiaoyu YANG , Huafei LUO
    doi: 10.16522/j.cnki.cjph.2022.05.006

    Transdermal drug delivery is an important drug delivery route for treating skin-related diseases, which has both advantages and limitations. The development and application of new carriers such as multi-microbubble dispersion and microsponges can improve stability and drug loading of different active ingredients in compound preparations for transdermal administration. The new adhesives can make patches enduringly adhere to the skin surface to realize continuous drug delivery. In this review, the dermatological preparations approved by FDA are selected, and the new carrier technologies are introduced, which might provide a reference for future research on topical and transdermal formulations.

  • Review
  • Wei WEI , Feng ZHAO , Yinling MA , Yaran BAO , Qing DU
    doi: 10.16522/j.cnki.cjph.2022.05.007

    Featured by self-administration, painless and minimally invasive surgery, direct drug delivery to the nidus, and controllable drug release, the microneedle technique enjoys a unique application prospect in treating dermatoses. Hence, it has become a research hotspot in dermatologic therapy and shows obvious therapeutic advantages. This review focuses on introducing the progress of researches at home and abroad on the treatment of hyperpigmentation, cicatrix, psoriasis, skin injury and tinea by microneedles, and further elaborates the perspectives of medicines, microneedle materials, and evaluations on therapeutic effects to provide a reference for skin disease treatment research.

  • Review
  • Xiaofei SI , Zhongheng ZHANG , Dianzhuo JIANG
    doi: 10.16522/j.cnki.cjph.2022.05.008

    At present, the oral modified-release preparations of bupropion hydrochloride have been widely used in antidepressant treatment, and the development of their generic drugs has also become one of the hot spots. There are great differences in the formulation process and quality control of different modified-release preparations. Based on analysis of relevant literature and the dossiers, some key points of the formulation process and quality control of oral bupropion hydrochloride modified-release preparations are discussed, and some general considerations about pharmaceutical studies are put forward, in order to provide certain references for the R&D of generic drugs. It's recommended to take clinical needs into account and conduct further in-depth pharmaceutical studies in combination with characteristics of drug substances and excipients as well as drug release mechanisms to ensure the consistency in quality and efficacy between the generic and reference drugs.

  • Review
  • Yaru SUN , Huilan JIANG , Yan JIANG , Rui DUAN , Gaoqi LYU
    doi: 10.16522/j.cnki.cjph.2022.05.009

    As a covering material for wounds, medical dressings can stop bleeding during the healing process, and can also act as a physical barrier against external microorganisms to reduce the probability of wound infection. With the development of science, medical dressings gradually trend to be functional and diversified. Collagen has the advantages of low immunogenicity, excellent biocompatibility and biodegradation, and it is used as a biological material in pharmaceutical and medical fields. Composite collagen-based dressings prepared with collagen as raw material and active ingredients have been gradually applied to superficial skin wounds and scalds, scar repair, antibacterial products for women, and repair after medical cosmetic surgery. This paper introduces the biological properties of collagen and the research progress of collagen-based medical dressings, which may provide a theoretical basis and new ideas for the research and development of medical dressings.

  • Paper
  • Cheng CHEN , Jinlu ZHONG , Tianxing CHENG , Xiang LI , Qingfang CHENG
    doi: 10.16522/j.cnki.cjph.2022.05.010

    In order to control the quality of cyclophosphamide, five related substances, namely N, N-bis(2-chloroethyl)-N'-(3-hydroxypropyl) phosphoric acid diamide acid chloride(related substance A), N, N-bis(2-chloroethyl)-N', N''-bis(3-hydroxypropyl) phosphoric triamide(related substance B), N, N-bis(2-chloroethyl)amido-chlorophosphate(3-aminopionate)(related substance C), N, N-bis(2-chloroethyl)phosphoramidate-bis(3-aminopionate)(related substance D), bis(2-chloroethyl)amido-phosphorsaeure-(3-aminopropyl)ester(related substance E), were prepared in this paper. Their structures were confirmed by MS and NMR.

  • Paper
  • Xiaorong JING , Jianlan CUI , Yanhong GAO , Mengge LIU
    doi: 10.16522/j.cnki.cjph.2022.05.011

    In this paper, 2-amino-5-chlorobenzophenone(1) or (2-amino-5-chlorophenyl)phenylmethanol(2) from 5-chloro-3-phenylbenzo[c]isoxazole(3) was obtained by selective reduction with thiourea dioxide. Compound 1 with the yield of 74.3% was obtained by the reaction of 3 with thiourea dioxide in 1∶4 molar ratio at 70 ℃ for 3 h. Compound 2 with the yield of 63.3% was obtained by the reaction of 3 with thiourea dioxide in 1∶17 molar ratio at 90 ℃ for 4 h. The advantages of this synthetic route are its simple operation, mild reaction conditions, and this process is green and environment-friendly.

  • Paper
  • Zhongsong ZHU , Lili ZHAO , Guimin ZHANG , Yu CAO , Zhong LIU
    doi: 10.16522/j.cnki.cjph.2022.05.012

    A mouse-derived cluster of differentiation 47(CD47) monoclonal antibody was screened by hybridoma technology. The polyethylene glycol fusion method was used to fuse mouse splenocytes with SP2/0 cells, and the anti-CD47 hybridoma cells were screened by enzyme-linked immunosorbent assay(ELISA). The antibody was purified by Protein G affinity column, and the relative molecular mass of the target protein was detected by sodium dodecyl sulfate(SDS)-polyacrylamide gel electrophoresis(PAGE). The affinity of the target antibody was detected by biomolecular interaction analyzer, and the blocking efficacy of signal regulatory protein α(SIRPα) of anti-CD47 antibody was determined by ELISA. Raji cells labeled with phycoerythrin(PE) were incubated with different concentrations of anti-CD47 monoclonal antibody, and the anti-CD47 antibody-promoted phagocytosis of macrophages was detected. The ability of anti-CD47 monoclonal antibody to induce red blood cell agglutination was analyzed by hemagglutination test, and the inhibitory effect of anti-CD47 monoclonal antibody on tumor growth was further investigated by mouse solid tumor model. The results showed that the screened hybridoma cell, anti-CD47 monoclonal antibody 3D8, had an affinity constant value of 1.29×10–11 mol/L, and its half effective concentration(EC50) value measured by ELISA was 0.17 nmol/L. It could effectively block the interaction between CD47 and SIRPα, and enhance the ability of macrophages to phagocytose tumor cells, with a phagocytosis rate of 85%. The anti-CD47 monoclonal antibody 3D8 was superior to the commercially available antibody in terms of affinity, blocking power, and phagocytosis rate, and did not cause red cell agglutination. In a mouse solid tumor model, the tumor growth inhibition rate of the product was 95.44%, indicating that it could significantly inhibit tumor growth. This study provided a reference for the later humanization of anti-CD47 antibody and preclinical research of anti-CD47 antibody.

  • Paper
  • Linyu SU , Xiaosu ZHU , Peng ZHANG , Sha LIU , Kaoxiang SUN
    doi: 10.16522/j.cnki.cjph.2022.05.013

    In this paper, proteolysis targeting chimeras(PROTAC) LC-2(1) encapsulated liposomes were designed and studied. The liposomes constructed by hydrogenated soybean phospholipid, cholesteryl hemisuccinate, lipids 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] were modified by octaarginine to increase the penetration ability of 1, aiming to solve the delivery dilemma. Several properties of the liposomes were characterized. The formulation and process parameters were optimized by single factor test and Box-Behnken design combined with response surface method with particle size and encapsulation efficiency as the indicators. The results showed that liposomes prepared by the improved ethanol injection method exhibited an average particle size of (117.3±0.6)nm with an encapsulation efficiency of (88.9±0.3)%. In vitro release profiles showed that the initial release behaviors were slightly different in phosphate buffer (PBS, pH 7.4) and PBS containing 50% of fetal bovine serum(FBS). However, about 50% of encapsulated agents were released in both media, indicating that the liposomes possessed a sustained-release characterization. Herein, the liposomes prepared by the improved ethanol injection method exhibited high encapsulation efficiency, appropriate particle size and good stability. The method for encapsulation efficiency determination had specific advantages, such as high sensitivity, simple operation, and high accuracy. The study would provide a reference for the study of in vivo delivery of PROTAC LC-2.

  • Paper
  • Yuehua GENG , Xinyu WANG , Ce DONG , Xin ZHANG
    doi: 10.16522/j.cnki.cjph.2022.05.014

    Under the guidance of an external magnetic field, the magnetic nanocapsules can transport drugs into cells or specific areas to achieve a therapeutic effect. In this study, the molecular dynamics mechanism and motion process of magnetic nanocapsules crossing the cell membrane were simulated to study the force of fullerene spheres(C720) and carbon nanotubes(CNT) nanocapsules with the same volume at different speeds. Furthermore, the transfer function model between the penetration speed and the force was established using the system identification method. The analytical model between the force of magnetic nanocapsules in the magnetic field and the external driving magnetic field was deduced. Combined with above three parts and the technical parameters of the magnetic field generating equipment, the magnetic intensity of external driving magnetic field required for the magnetic nanocapsules to cross the blood-brain barrier was solved. The results showed that the force needed to overcome by fullerene spheres was less than that of carbon nanotubes when nanocapsules with the same volume penetrated the membrane at a uniform speed, which could be used as a simulation basis for magnetic field in an MRI scanner to drive magnetic nanocapsules to complete the membrane penetration.

  • Paper
  • Xilong QU , Tiejian LI , Zhijun LIU , Ruixia WEI , Guimin ZHANG
    doi: 10.16522/j.cnki.cjph.2022.05.015

    A normal phase high performance liquid chromatography was established for the simultaneous determination of the enantiomer(2) and the diastereomers Ⅰ and Ⅱ(3 and 4) in tert-butyl rosuvastatin(1). A Daicel CHIRALPAK® AD-H chiral column(4.6 mm×250 mm, 5 μm) was adopted with n-hexane∶n-propanol(90∶10) as the mobile phase(isocratic elution). The UV detection wavelength was 242 nm, the flow rate was 1.0 ml/min, and the column temperature was 25 ℃. The results showed that the established method had good specificity, and it was linear for 1 - 4 in the corresponding concentration ranges. The average recoveries(n=9) of 2, 3, and 4 were 97.2%, 96.5% and 97.6% with the RSDs of 4.1%, 3.6% and 3.1%, respectively. The established method is simple and sensitive, which can be used for the detection of the enantiomer and diastereomers in 1.

  • Paper
  • Xuemei WEN , Hongjuan PAN , Yue LI , Jing LU
    doi: 10.16522/j.cnki.cjph.2022.05.016

    An LC-MS method was established to analyze the forced degradation samples of lanreotide acetate by oxidation, high temperature and alkali destructions. The results showed that eight degradation impurities were found. High resolution mass spectrometry(HRMS/MS) was used to analyze the structures of the main degraded impurities and the degradation mechanism was also discussed. The single S and S-S-S structures in impurities were further verified by the reduction test of dithiothreitol(DTT). This paper provides a reference for the studies of the degradation impurity profile and related quality control standards of this drug. In addition, it also provides some references for the study of potential degradation impurities of some cyclic peptides ringed by disulfide bridges.

  • Paper
  • Ye ZHANG , Dongmei SONG , Yang CHEN , Jian LE
    doi: 10.16522/j.cnki.cjph.2022.05.017

    An inductively coupled plasma-atomic emission spectroscopy(ICP-AES) method was established to determine the residue of palladium in iopamidol(1). Compound 1 was dissolved in diluted hydrochloric acid, and the ICP-AES method was used to determine the residual amount of palladium with scandium as the internal standard. The results showed that it was linear for palladium in the range of 0.04 - 0.4 μg/ml, and the detection and quantification limits were 0.014 and 0.048 μg/g, respectively. The average recovery(n=9) was 92.7%, with the RSD of 1.8%. The sample determination results showed that the residual amounts of palladium in five batches of 1 were all lower than the detection limit. The established method is simple, sensitive and accurate, which can be used for the determination of residual palladium in 1.

  • Paper
  • Baoxia TENG , Lu YU , Jianping MU , Jinghui LIU , Xiaowen HE
    doi: 10.16522/j.cnki.cjph.2022.05.018

    An evaporative light scattering detector-high performance liquid chromatography(ELSD-HPLC) method was established to determine the content of poloxamer 188(2) in recombinant human interferon α2b(1)injection. The spherical hydrophilic silica gel TSKgel G3000SW column(7.5 mm×600 mm, 10 μm) was used with water∶acetonitrile(75∶25) as mobile phase(isocratic elution). The flow rate was 0.6 ml/min, the drift tube temperature was 105 ℃, and the carrier gas flow was 3.0 L/min. The results showed that it was linear for 2 in the range of 0.1 -1.25 mg/ml. The average recovery(n=9) of 2 was 101.2%, with the RSD of 0.5%. The established method is highly specific, which can be used for the determination of 2 in 1 injection.

  • Paper
  • Diandian WANG , Xilong LI , Yinhua ZHU , Yimin HUA
    doi: 10.16522/j.cnki.cjph.2022.05.019

    The methods for the determination of C12 - C28 alkanes, antioxidants, sulfur and metal elements in 0.9% sodium chloride injection pre-filled flush syringes were established, and the compatibility of 0.9% sodium chloride injection and pre-filled flush syringe was investigated by the extraction, migration and adsorption tests. The C12 - C28 alkanes were determined by gas chromatography-mass spectrometry/hydrogen flame ionization detection with detection limits of 0.023 - 0.029 μg/ml. The antioxidants and sulfur were determined by high performance liquid chromatography with detection limits of 0.019 - 0.133 μg/ml. The metal elements were determined by inductively coupled plasma mass spectrometry with detection limits of 0.000 28 - 0.015 9 μg/ml. All the above detection methods met the sensitivity requirements. The contents of all the extractables in the simulated extraction test were lower than the analytical evaluation threshold(AET) values. The contents of the leachables were all lower than the permitted daily exposure(PDE) values, and no adsorption of sodium chloride was observed. The results showed that the 0.9% sodium chloride injection had good compatibility with the pre-filled flush syringe, which provided a reference for the compatibility study of this type of drug packaging materials.

  • Pharmaceutical Management & Information
  • Yun WANG , Jianwei ZHU
    doi: 10.16522/j.cnki.cjph.2022.05.020
  • Pharmaceutical Management & Information
  • Yong YU , Jun YAN , Yongan ZHU , Baiyang CHEN , Shuxia HU , Yiming XU
    doi: 10.16522/j.cnki.cjph.2022.05.021
  • Pharmaceutical Management & Information
  • Ling ZHANG , Yanan WANG , Jiawen ZHU , Rong SHAO , Rong JIANG
    doi: 10.16522/j.cnki.cjph.2022.05.022
  • Pharmaceutical Management & Information
  • Jia ZHU , Tao XU , Cheng WANG , Kailun HE , Qiaofeng TAO
    doi: 10.16522/j.cnki.cjph.2022.05.023
  • Pharmaceutical Management & Information
  • Qiqi ZHANG , Linlin BU , Hong SU
    doi: 10.16522/j.cnki.cjph.2022.05.024
News